Showing results (591-600 of 610) with videos related to
Sort By:
Pageof 61
Nature Communications|July 2, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug RegistrationKenneth C Anderson, Daniel Auclair, Stacey J Adam, et al.Nature Communications|February 13, 2021
PRMT5 inhibition disrupts splicing and stemness in glioblastomaPatty Sachamitr, Jolene C Ho, Felipe E Ciamponi, et al.Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.Nature Genetics|June 30, 2015
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F Eleveld, Derek A Oldridge, Virginie Bernard, et al.Nature Genetics|January 22, 2013
The genetic landscape of high-risk neuroblastomaTrevor J Pugh, Olena Morozova, Edward F Attiyeh, et al.Nature|January 7, 2014
Landscape of genomic alterations in cervical carcinomasAkinyemi I Ojesina, Lee Lichtenstein, Samuel S Freeman, et al.Cancer Discovery|October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD ConsortiumAnirban Das, Nicholas R Fernandez, Adrian Levine, et al.Pageof 61